Heart failure is a growing public health concern. Advanced heart failure is frequently associated with severe muscle wasting, termed cardiac cachexia. This process is driven by systemic inflammation and tumor necrosis factor in a manner common to other forms of disease-related wasting seen with cancer or human immunodeficiency virus. A variable degree of malnutrition is often superimposed from poor nutrient intake. Cardiac cachexia significantly decreases quality of life and survival in patients with heart failure. This review outlines the evaluation of nutrition status in heart failure, explores the pathophysiology of cardiac cachexia, and discusses therapeutic interventions targeting wasting in these patients.
SoukoulisVDihuJBSoleM. Micronutrient deficiencies an unmet need in heart failure. J Am Coll Cardiol. 2009;54(18):1660-1673.
2.
GrossniklausDAO’BrienMCClarkPCDunbarSB.Nutrient intake in heart failure patients. J Cardiovasc Nurs. 2008;23(4):357-363.
3.
Centers for Disease Control and Prevention (CDC). CDC Heart Failure Fact Sheet. Atlanta, GA: CDC; 2012.
4.
YancyCWJessupMBozkurtB. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147-e239.
5.
WhiteJVGuenterPJensenG. Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition). JPEN J Parenter Enteral Nutr. 2012;36(3):275-283.
6.
AquilaniROpasichCVerriM. Is nutritional intake adequate in chronic heart failure patients?J Am Coll Cardiol. 2003;42(7):1218-1223.
7.
AquilaniROpasichCGualcoA. Adequate energy-protein intake is not enough to improve nutritional and metabolic status in muscle-depleted patients with chronic heart failure. Eur J Heart Fail. 2008;10(11):1127-1135.
8.
AnkerSDNegassaACoatsAJS. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 2003;361(9363):1077-1083.
9.
CampilloBPaillaudEUzanI. Value of body mass index in the detection of severe malnutrition: influence of the pathology and changes in anthropometric parameters. Clin Nutr. 2004;23(4):551-559.
10.
KyleUGUngerPDupertuisYMKarsegardVLGentonLPichardC. Body composition in 995 acutely ill or chronically ill patients at hospital admission. J Am Diet Assoc. 2002;102(7):944-955.
11.
CurtisJPSelterJGWangY. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165(1):55-61.
12.
KenchaiahSPocockSJWangD. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Program. Circulation. 2007;116(6):627-636.
13.
DetskyASMcLaughlinJRBakerJP. What is subjective global assessment of nutritional status?JPEN J Parenter Enteral Nutr. 1987;11(1):8-13.
14.
YamautiAKOchiaiMEBifulcoPS. Subjective global assessment of nutritional status in cardiac patients. Arq Bras Cardiol. 2006;87(6):772-777.
15.
StrattonRJHackstonALongmoreD. Malnutrition in hospital outpatients and inpatients: prevalence, concurrent validity and ease of use of the ‘malnutrition universal screening tool’ (‘MUST’) for adults. Br J Nutr. 2007;92(5):799.
16.
ChermeshIHajosJMashiachT. Malnutrition in cardiac surgery: food for thought. Eur J Prev Cardiol. 2014;21(4):475-483.
17.
AraújoJPLourençoPRocha-GonçalvesFFerreiraABettencourtP. Nutritional markers and prognosis in cardiac cachexia. Int J Cardiol. 2011;146(3):359-363.
18.
Haehling vonSLainscakMSpringerJAnkerSD. Cardiac cachexia: a systematic overview. Pharmacol Ther. 2009;121(3):227-252.
19.
ChristensenHMKistorpCSchouM. Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status. Endocrine. 2012;43(3):626-634.
20.
ConraadsVMBosmansJMVrintsCJ. Chronic heart failure: an example of a systemic chronic inflammatory disease resulting in cachexia. Int J Cardiol. 2002;85(1):33-49.
21.
CogginsMRosenzweigA. The fire within: cardiac inflammatory signaling in health and disease. Circ Res. 2012;110(1):116-125.
22.
LevineBKalmanJMayerLFillitHMPackerM. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323(4):236-241.
23.
DavisMP. Appetite and cancer-associated anorexia: a review. J Clin Oncol. 2004;22(8):1510-1517.
BorstSE. The role of TNF-α in insulin resistance. Endocrine. 2004;23(2-3):177-182.
29.
DoehnerWRauchhausMGodslandIF. Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha. Int J Cardiol. 2002;83(1):73-81.
30.
RontiTLupattelliGMannarinoE. The endocrine function of adipose tissue: an update. Clin Endocrinol. 2006;64(4):355-365.
31.
AnkerSDChuaTPPonikowskiP. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 1997;96(2):526-534.
32.
PfuntnerA. Statistical Brief #148: Most Frequent Conditions in U.S. Hospitals, 2010. Rockville, MD: Agency for Healthcare Research and Quality, 2012: 1-11.
33.
AzizEFJavedFPratapB. Malnutrition as assessed by nutritional risk index is associated with worse outcome in patients admitted with acute decompensated heart failure: an ACAP-HF data analysis. Heart Int. 2011;6(1):e2.
34.
JensenGLCompherCSullivanDHMullinGE. Recognizing malnutrition in adults: definitions and characteristics, screening, assessment, and team approach. JPEN J Parenter Enteral Nutr. 2013;37(6):802-807.
35.
LoncarGFülsterSHaehling vonSPopovicV. Metabolism and the heart: An overview of muscle, fat, and bone metabolism in heart failure. Int J Cardiol. 2013;162(2):77-85.
36.
ZamboniMRossiAPCorzatoFBambaceCMazzaliGFantinF. Sarcopenia, cachexia and congestive heart failure in the elderly. Endocr Metab Immune Disord Drug Targets. 2013;13(1):58-67.
37.
NeubauerS. The failing heart—an engine out of fuel. N Engl J Med. 2007;356(11):1140-1151.
38.
FaddanNHSayh ElKShamsHBadrawyH. Myocardial dysfunction in malnourished children. Ann Pediatr Cardiol. 2010;3(2):113.
39.
El-SayedHLNassarMFHabibNMElmasryOAGomaaSM. Structural and functional affection of the heart in protein energy malnutrition patients on admission and after nutritional recovery. Eur J Clin Nutr. 2005;60(4):502-510.
40.
OlivaresJLVázquezMFletaJMorenoLAPérez-GonzálezJMBuenoM. Cardiac findings in adolescents with anorexia nervosa at diagnosis and after weight restoration. Eur J Pediatr. 2005;164(6):383-386.
41.
KastnerSSalbach-AndraeHRennebergBPfeifferELehmkuhlUSchmitzL. Echocardiographic findings in adolescents with anorexia nervosa at beginning of treatment and after weight recovery. Eur Child Adolesc Psychiatry. 2011;21(1):15-21.
42.
DunnSPBleskeBDorschMMacaulayTVan TassellBVardenyO. Nutrition and heart failure: impact of drug therapies and management strategies. Nutr Clin Pract. 2009;24(1):60-75.
43.
YancyCWJessupMBozkurtB. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128(16):e240-e327.
44.
KeithMEWalshNADarlingPB. B-vitamin deficiency in hospitalized patients with heart failure. J Am Diet Assoc. 2009;109(8):1406-1410.
45.
WitteKKAClarkAL. Chronic heart failure and multiple micronutrient supplementation: realistic hope or idealistic conjecture?Heart Fail Monit. 2005;4(4):123-129.
46.
SakkasGKSchambelanMMulliganK. Can the use of creatine supplementation attenuate muscle loss in cachexia and wasting?Curr Opin Clin Nutr Metab Care. 2009;12(6):623-627.
47.
MolfinoACostelliPAversaZBaccinoFMFanelliFRMuscaritoliM. Statins, coenzyme Q10, and cachexia: what’s the link?Am J Cardiol. 2007;100(9):1497-1498.
GotsmanIShauerAZwasDR. Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome. Eur J Heart Fail. 2012;14(4):357-366.
50.
DalbeniAScaturroGDeganMMinuzPDelvaP. Effects of six months of vitamin D supplementation in patients with heart failure: a randomized double-blind controlled trial. Nutr Metab Cardiovasc Dis. 2014;24(8):861-868.
51.
SandersPMRussellSTTisdaleMJ. Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia. Br J Cancer. 2005;93(4):425-434.
52.
AdigunAQAjayiAL. The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia. Eur J Heart Fail. 2001;3(3):359-363.
53.
OnderGPenninxBWBalkrishnanR. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet. 2002;359(9310):926-930.
54.
AnkerSDLechatPDargieHJ. Prevention and reversal of cachexia in patients with chronic heart failure by bisoprolol: results from the CIBIS-II study. J Am Coll Cardiol. 2003;41(6):156A-157A.
55.
AnkerSDCoatsARoeckerEBScherhagAPackerM. Does carvedilol prevent and reverse cardiac cachexia in patients with severe heart failure? Results of the COPERNICUS study. Eur Heart J. 2002;23:394-394.
56.
HerndonDNHartDWWolfSEChinkesDLWolfeRR. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med. 2001;345(17):1223-1229.
57.
HuntSAAbrahamWTChinMH. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult—summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46(6):1116-1143.
58.
SpringerJTschirnerAHaghikiaA. Prevention of liver cancer cachexia-induced cardiac wasting and heart failure. Eur Heart J. 2014;35(14):932-941.
59.
van der HarstPde BoerRA. Statins in the treatment of heart failure. Circ Heart Fail. 2010;3(3):462-464.
60.
SadekMMHaddadTHaddadH. The role of statins in chronic heart failure. Curr Opin Cardiol. 2009;24(2):167-171.
61.
KjekshusJApetreiEBarriosV. Rosuvastatin in older patients with systolic heart failure. N Engl J Med. 2007;357(22):2248-2261.
62.
TavazziLMaggioniAPMarchioliR. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9645):1231-1239.
63.
YancyCWJessupMButlerJ. 2013AHA guidelines for the management of heart failure. J Am Coll Cardiol. 2013;62(16):e147-e239.
64.
SlaughterMSPaganiFDRogersJG. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29(S):S1-S39.
65.
HoldyKDembitskyWEatonLL. Nutrition assessment and management of left ventricular assist device patients. J Heart Lung Transplant. 2005;24(10):1690-1696.
66.
TaziEMErrihaniH. Treatment of cachexia in oncology. Indian J Palliat Care. 2010;16(3):136.
67.
IversenL. Cannabis and the brain. Brain. 2003;126(6):1252-1270.
68.
SidneyS. Cardiovascular consequences of marijuana use. J Clin Pharmacol. 2002;42(11)(suppl):64S-70S.
69.
GullettNPHebbarGZieglerTR. Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting. Am J Clin Nutr. 2010;91(4):1143S-1147S.
70.
PughP. Acute haemodynamic effects of testosterone in men with chronic heart failure. Eur Heart J. 2003;24(10):909-915.
71.
TomaMMcAlisterFACoglianeseEE. Testosterone supplementation in heart failure: a meta-analysis. Circ Heart Fail. 2012;5(3):315-321.
72.
BaughmanKLJarchoJA. Bridge to life—cardiac mechanical support. N Engl J Med. 2007;357(9):846-849.
73.
PrattAKShahNSBoyceSW. Left ventricular assist device management in the ICU. Crit Care Med. 2014;42(1):158-168.
74.
EngelmanDTAdamsDHByrneJG. Impact of body mass index and albumin on morbidity and mortality after cardiac surgery. J Thorac Cardiovasc Surg. 1999;118(5):866-873.
75.
SanchezJASanchezLLDudrickSJ. Nutritional considerations in adult cardiothoracic surgical patients. Surg Clin North Am. 2011;91(4):857-875.
76.
PotapovEVLoebeMAnkerS. Impact of body mass index on outcome in patients after coronary artery bypass grafting with and without valve surgery. Eur Heart J. 2003;24(21):1933-1941.
77.
RussoMJHongKNDaviesRR. The effect of body mass index on survival following heart transplantation. Ann Surg. 2010;251(1):144-152.
78.
ClarkALKnosallaCBirksELoebeM. Heart transplantation in heart failure: the prognostic importance of body mass index at time of surgery and subsequent weight changes. Eur J Heart Fail. 2007;9(8):839-844.
79.
ManoAFujitaKUenomachiK. Body mass index is a useful predictor of prognosis after left ventricular assist system implantation. J Heart Lung Transplant. 2009;28(5):428-433.
80.
ClarkALLoebeMPotapovEV. Ventricular assist device in severe heart failure: effects on cytokines, complement and body weight. Eur Heart J. 2001;22(24):2275-2283.
81.
MusciMLoforteAPotapovEV. Body mass index and outcome after ventricular assist device placement. Ann Thorac Surg. 2008;86(4):1236-1242.
82.
MontgomeryTDCohenAEGarnickJSpadaforeJBoldeaE. Nutrition assessment, care, and considerations of ventricular assist device patients. Nutr Clin Pract. 2012;27(3):352-362.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
